Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Versatile wastewater monitoring of pathogens and antimicrobial resistance enabled by metatranscriptomics and long-read metagenomics.
Journal: Research square
Published: September 18, 2025
Spef1 is a microvillar component that limits apical actomyosin contractility and preserves intestinal barrier function.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Microbiome 2.0: lessons from the 2024 Gut Microbiota for Health World Summit.
Journal: Gut microbes
Published: September 10, 2024
Recommendations to Improve Quality of Probiotic Systematic Reviews With Meta-Analyses.
Journal: JAMA network open
Published: December 08, 2023
Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections.
Journal: Open forum infectious diseases
Published: September 11, 2023
Presentation of the Julius M. Friedenwald Medal to Sheila E. Crowe, MD.
Journal: Gastroenterology
Published: April 16, 2023
Gut microbiota and microbiota-based therapies for Clostridioides difficile infection.
Journal: Frontiers in medicine
Published: November 08, 2022
Spef1/CLAMP binds microtubules and actin-based structures and regulates cell migration and epithelia cell polarity.
Journal: Annals of the New York Academy of Sciences
Published: June 17, 2022
Clinical Manifestations and Stool Load of Atypical Enteropathogenic Escherichia coli Infections in United States Children and Adults.
Journal: Gastroenterology
Published: January 18, 2022
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
Journal: BMC infectious diseases
Published: October 11, 2021
Last Updated: 09/26/2026